Today, the U.S. FDA approved one of our therapies as an adjunctive treatment for adults living with major depressive disorder (MDD) – offering hope to the 2 in 3 patients who experience residual symptoms despite their antidepressant treatment. Learn more here:

What's the difference between AI hype and AI value in healthcare? At #HLTHUSA, our CIO Jim Swanson shared what successful teams focus on to deliver real results that advance health.

Driven by our commitment to closing the gap between communities and care, we're excited to announce that we're teaming up with the @nyjets to promote better health in the local community, which is home to both our world headquarters and the Jets. Join us in honoring healthcare

We’re gearing up for #HLTHUSA October 19-22. Don’t miss sessions on AI’s real-world impact, breaking barriers in cancer care and how nurses are fueling healthcare innovation: https://t.co/bGEEXuwuev

Join our Q3 2025 #earnings call and webcast now: https://t.co/EEGU1oWveE $JNJ

Today we’re announcing our intent to separate our Orthopaedics business. We’re confident this move would further strengthen the focus of Johnson & Johnson on our six key growth areas – Oncology, Immunology, Neuroscience, Cardiovascular, Surgery, and Vision. It would also

Struggling to see clearly due to astigmatism and finding it hard to focus up close from presbyopia? We're changing that with ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM—the first and only daily disposable contact lens designed to treat both astigmatism and presbyopia.¹

Join our Q1 2025 #earnings call and webcast now: https://t.co/rPwdB5Fw93 $JNJ

Today we’re breaking ground on our new biologics manufacturing site in Wilson, North Carolina, to help deliver transformational medicines for people living with cancer, immune-mediated, and neurological diseases. Learn more: https://t.co/Q0nqJlOShp #JNJSupplyChain

We’re expanding U.S. manufacturing, technology and research & development of innovative healthcare solutions to impact health for humanity: https://t.co/olfWhwlbGw

Join our Q4 and full-year 2024 #earnings call and webcast now: https://t.co/JxprBXhiCt $JNJ

We’re proud to be recognized as a top 5 company by @atmindex. See how we're harnessing our capabilities, reach and resources to help people around the world get the care they need: https://t.co/tYW1SsGQgv

We're using AI and other innovative technology in new ways to advance healthcare—from improving surgical training and medical procedures to personalizing care for patients around the world. Discover more: https://t.co/T75AQsmpEZ

"Together, advances in science and technology will lead to more effective and personalized treatments." Our Chairman & CEO Joaquin Duato took the stage at @HLTHEVENT to share why now is the time for bold ambition in healthcare. #HLTHUSA

How would the world change if everyone had equal access to healthcare? @johnlegend joined our EVP, Global Corporate Affairs, Vanessa Broadhurst, at @HLTHEvent for a powerful conversation on the importance of driving culturally competent care to unlock health equity.

We're at @HLTHEVENT to share how we're using innovative technologies to advance healthcare—including creating more personalized care strategies for patients. Follow along for updates!

We're heading to @HLTHEVENT from October 20-23 to share how we're harnessing innovative technologies to revolutionize healthcare. Swipe to explore what you can learn from our leaders:

See a recap of our Q3 2024 #earnings here: https://t.co/JB2xKRA7f1 $JNJ

Joe Wolk, Executive Vice President and Chief Financial Officer, #JNJ, on our Q3 2024 #earnings results. Go to our Investor Relations site for more information: https://t.co/55Lxa9B53w $JNJ

Joaquin Duato, Chairman and Chief Executive Officer, #JNJ, on our Q3 2024 #earnings results and financial performance. Read the release for details, non-GAAP reconciliations and cautionary statements: https://t.co/y0Om50w9TL $JNJ